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Suppressor of fused links Fused and Cubitus interruptus on the
Hedgehog signalling pathway
Véronique Monnier, François Dussillol, Georges Alves, Claudie Lamour-Isnard
and Anne Plessis
The Hedgehog (Hh) family of signalling proteins [1]
mediate inductive interactions either directly or by
controlling the transcription of other secreted proteins
through the action of Gli transcription factors, such as
Cubitus interruptus (Ci) [2]. In Drosophila, the
transcription of Hh targets requires the activation of the
protein kinase Fused (Fu) and the inactivation of both
Suppressor of fused (Su(fu)) and Costal-2 (Cos-2) [3].
Fu is required for Hh signalling in the embryo and in the
wing imaginal disc and acts also as an antitumorigen in
ovaries [4]. All fu– phenotypes are suppressed by the
loss of function of Su(fu) [5]. Fu, Cos-2 and Ci are co-
associated in vivo in large complexes that are bound to
microtubules in a Hh-dependent manner [6,7]. Here we
investigate the role of Su(fu) in the intracellular part of
the Hh signalling pathway. Using the yeast two-hybrid
method and an in vitro binding assay, we show that
Su(fu), Ci and Fu can interact directly to form a
trimolecular complex, with Su(fu) binding to both its
partners simultaneously. Su(fu) and Ci also co-
immunoprecipitate from embryo extracts. We propose
that, in the absence of Hh signalling, Su(fu) inhibits Ci
by binding to it and that, upon reception of the Hh
signal, Fu is activated and counteracts Su(fu), leading
to the activation of Ci. 
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Results and discussion
Su(fu) is a novel protein containing a PEST sequence, a
sequence that has been associated with rapidly degraded
proteins. Su(fu) has been shown by genetic means to
antagonize fu in a dose-dependent manner [8]. To estab-
lish whether Fu could interact with Su(fu) at the molecu-
lar level, we first used a two-hybrid assay [9]. We
co-expressed two fusion proteins in yeast: Su(fu) fused to
the DNA-binding domain of LexA (LexA–Su(fu)), and
the carboxy-terminal putative regulatory domain of Fu
(Fu-reg; amino acids 306–805) fused to a transactivation
domain B42 (B42–Fu-reg). The two reporter genes (lacZ
and LEU2) were specifically activated in the presence of
the two-hybrid proteins, as attested by the appearance of a
Leu+ phenotype and the production of β-galactosidase
(Figure 1a). In the controls, no such activation was
observed. The β-galactosidase activity induced by interac-
tion of LexA–Su(fu) and B42–Fu-reg was about 70-fold
higher than the sum of the activities of the corresponding
control strains (see Table S1 in Supplementary material,
published with this paper on the internet). Using deletion
analysis, we established that the region of Fu-reg that
spans amino-acid residues 306–436 was sufficient for its
interaction with Su(fu) (Figure 1a). Three sequence ele-
ments that are highly conserved between D. virilis and D.
melanogaster are present within this domain [10]. 
To rule out the existence of a yeast protein mediating the
interaction shown above, we carried out an in vitro bio-
chemical assay. We tested the ability of a bacterially pro-
duced glutathione-S-transferase–Su(fu) fusion protein
(GST–Su(fu)) to bind to [35S]methionine-labelled Fu or
Fu-reg synthesized in vitro from a rabbit reticulocyte
extract. As shown in Figure 1b, GST–Su(fu) can bind
specifically to both the regulatory domain of Fu and the
full-length Fu protein. 
Although no direct target for Fu has been identified so far,
it has been shown to act upstream of Ci [11]. Ci plays a
dual role in Hh signalling. In the absence of the Hh signal,
cleavage of Ci turns it into a transcriptional repressor,
whereas Hh signalling prevents Ci truncation, leading to
the accumulation of a full-length form of Ci which is
thought to be transcriptionally active [12]. To test whether
Fu affects Ci directly, or through Su(fu), we tested for
interactions between Ci and Fu or Su(fu). Using the two-
hybrid assay, we could detect no interaction between Ci
and Fu-reg (see later). In contrast, co-expression of
B42–Ci and LexA–Su(fu) specifically activated both
reporter genes, leading to a more than 30-fold increase in
β-galactosidase activity (Figure 2a; Table S1 in Supple-
mentary material). The first 346 amino-terminal residues
of Ci (Ci-∆346) were sufficient to mediate the latter’s
interaction with Su(fu) (Figure 2). This domain contains
several sequences that are conserved among Gli proteins.
As shown in Figure 2b, [35S]methionine-labelled Ci syn-
thesized in vitro was specifically retained by the
GST–Su(fu) fusion protein, but not by GST alone, thus
confirming the existence of a direct physical interaction
between Su(fu) and Ci proteins. 
So far our results have provided evidence for direct inter-
actions between Su(fu) and Fu, and between Su(fu) and
Ci. We then tested whether Su(fu) could simultaneously
link both Fu and Ci. As shown in Figure 3, expression of
Su(fu) together with the B42–Ci and LexA–Fu-reg fusion
proteins led to the activation of the LEU2 reporter,
whereas no activation was observed when any one of the
three partners was replaced by a control. Therefore, Su(fu)
can act as a bridge between Fu-reg and Ci, the three pro-
teins forming a trimeric complex.
The biological relevance of these interactions is supported
by previously reported genetic data and by the fact that Ci
and Fu co-immunoprecipitate [7]. Furthermore, using an
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Figure 1
Su(fu) interacts specifically with Fu-reg. (a) Yeast two-hybrid
interaction β-galactosidase assay (left) and Leu assay (right). Each dot
corresponds to a colony of the yeast strain EGY48–pSH18-34 (see
Materials and methods) co-transformed with an expression plasmid
pEG202 (columns) containing the DNA-binding domain of LexA fused
to Su(fu) or to a monomeric GTP-binding protein Rab3, and a second
plasmid pJG4-5 (rows) containing B42 fused to full-length Fu-reg or
the indicated truncated versions of Fu-reg (the amino acids expressed
are indicated) or to the β-subunit of geranylgeranyl transferase
(GGTIIβ). Rab3 and GGTIIβ are two human proteins known to interact
with each other. In this system, an interaction results in the activation of
the two reporter genes (lacZ and LEU2) placed under the control of
LexA-binding sites. The blue colour developed within 20 min of
reaction and growth on media lacking leucine was visible after less
than 48 h at 30°C (see also Table S1 in Supplementary material). Each
test was performed independently at least four times. We could test
neither the whole Fu protein, nor its catalytic domain alone, as the
presence of the kinase domain (but not its kinase catalytic activity)
seems to block any interaction in this yeast system (our unpublished
observations). (b) In vitro interaction assay. In vitro translated,
[35S]methionine-labelled Fu-reg (lanes 1–3) and Fu (lanes 4–6) before
(lanes 1,4) or after (lanes 2,5) incubation with GST–Su(fu), or with
GST alone (lanes 3,6) immobilized on glutathione–Sepharose beads.
The amount of protein input was about half that of the protein used for
the assay. The specificity of the interactions was demonstrated by the
absence of retention of any radiolabelled protein in the control
experiments (lanes 3,6,7). 77K is a human polyadenylation protein
included as a control. The arrows indicate the positions of the
corresponding full-length 35S-labelled proteins. In vitro synthesis of Fu
and Fu-reg consistently produced a doublet, both bands being
resistant to phosphatase treatment (data not shown) and both binding
to Su(fu). Protein size markers are shown to the left in kDa.
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Figure 2
Su(fu) interacts specifically with Ci. (a) Yeast two-hybrid interaction
β-galactosidase assay (left) and Leu assay (right) performed as
described in the legend to Figure 1 except that the pJG4-5 plasmid
contained B42 fused to full-length Ci or a truncated version of Ci
(amino acids 1–346; Ci-∆346). See also Table S1 in Supplementary
material. (b) In vitro interaction assay. In vitro translated,
[35S]methionine-labelled Ci (lanes 1–3) before (lane 1) or after (lane 2)
incubation with GST–Su(fu), or with GST alone (lane 3). GST–Su(fu)
interaction with Ci still occurred at 200 mM NaCl, although it was
weaker (data not shown). The arrow indicates the position of the
corresponding full-length 35S-labelled Ci protein. See also legend to
Figure 1. (c) Ci and Su(fu) co-immunoprecipitate from embryonic
extracts. Immunoprecipitations with a rabbit antibody directed against
Su(fu) were performed on embryonic extracts from a Drosophila wild-
type strain (Oregon R; lanes 1,2) or from a strain deficient for Su(fu)
(Df(3R)karSZ11/Df(3R)karSZ21; lanes 3,4) [12]. The total pellet
immunoprecipitated (IP; lanes 2,4) and 1/50 of each supernatant (S;
lanes 1,3) were analysed by western blotting using an anti-Ci
monoclonal antibody (mAb 2A1). This antibody allowed only the
detection of the full-length Ci (155 kDa; arrow).
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anti-Su(fu) immunoserum, we were able to co-immuno-
precipitate full-length Ci from wild-type embryo extracts
but not from mutant embryos deficient for Su(fu) (Figure
2c). We were unable to draw any conclusions about Fu
because of the presence of background at the correspond-
ing position (data not shown). 
Our results shed new light on the recent observation that
large complexes that contain Fu and Ci as well as Cos-2
are present in embryonic extracts [6,7]. We demonstrate
here that the Fu–Ci interaction is not direct but is medi-
ated by Su(fu). We propose that Su(fu) prevents Ci tran-
scriptional activity and that, upon Hh reception, this
inhibition is opposed by the negative effect of Fu on
Su(fu) as described in the model presented in Figure 4.
This model is in agreement with the embryonic expres-
sion pattern of one Hh target gene, wingless (wg), in fu– and
Su(fu)– mutants [5]. In fact, it is possible that the absence
of wg expression in fu– mutants results from a constitutive
inhibition of Ci by Su(fu). In contrast, in Su(fu)–, as in
fu– Su(fu)– double mutants, Ci escapes from the control of
Su(fu) and as a consequence no longer requires the action
of Fu to transactivate wg. The control of Ci activity by
Su(fu) might rely on the cytoplasmic retention of Ci, like
the Rel transcription factor NF-κB/Dorsal which is regu-
lated by its cytoplasmic retention by I-κB/Cactus [13].
Here, Fu activation possibly triggers the degradation of
Su(fu) through the phosphorylation of its PEST
sequence. We could not, however, detect any significant
change in the subcellular localization of full-length Ci in
wing imaginal discs of Su(fu)– mutants (data not shown).
One interpretation of this observation is that the control
exerted by Su(fu) on Ci occurs at another level, for
instance by controlling Ci processing. 
Su(fu) function is probably redundant as it is dispensable
in an otherwise wild-type context. Ci transactivating activ-
ity is probably also under the negative control of another
Hh antagonist — the kinesin-related protein Cos-2.
Several lines of evidence uphold this hypothesis. First, in
cos-2 mutants, the processing of Ci into a repressor form is
reduced; second, Cos-2, like Su(fu), acts as an antagonist of
Fu: the loss of Fu kinase activity is suppressed by the loss
of function of either Cos-2 or Su(fu), whereas the loss of
Su(fu) function enhances the Cos-2 phenotype [5]; and
third, Cos-2 co-immunoprecipitates with both Fu and Ci in
embryo extracts [6,7]. Thus it is likely that, in the absence
of Su(fu), Fu and Ci would remain associated through Cos-
2. An attractive hypothesis is that Cos-2 retains Ci within
the cytoplasm by anchoring it to microtubules. 
In the future, the exploration of the interactions between
other known components of the Hh signalling pathway
and a search for new components will be important for
the elucidation of the molecular mechanisms involved.
Given the high level of evolutionary conservation of the
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Figure 3
Su(fu), Ci and Fu form a trimeric complex in yeast. EGY48 cells were
co-transformed with (a) pEG202 encoding LexA–Fu-reg (rows 1,3,4)
or LexA–Rab3 (row 2), (b) pJG4-5 encoding B42–Ci (rows 1,2,4) or
B42–GGTIIβ (row 3), and (c) a third plasmid pYEF2 with no insert
(row 1) or one expressing Su(fu) (rows 2–4). It was not possible to
test the induction of the lacZ reporter plasmid as it carried the same
marker as the third plasmid (see Materials and methods). 
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Figure 4
Model for interactions between Ci, Su(fu) and Fu. (a) In the absence of
the Hh signal, Fu, Ci, Su(fu) and Cos-2 are part of a cytoplasmic
complex bound to microtubules through Cos-2. Su(fu) and Cos-2 exert
an inhibitory effect on Ci by binding to it (directly for Su(fu), directly or
indirectly for Cos-2). This facilitates the processing of Ci into its
truncated repressor form (Ci-rep). Although its precise role in the
pathway is not known, protein kinase A (PKA) also acts as an
antagonist of Hh [16]. (b) The reception of the Hh signal leads to
activation of Fu, which triggers the dissociation of Su(fu) and Ci,
possibly through Su(fu) degradation. It also opposes the inhibitory
activity of Cos-2 by releasing it from the microtubules. Consequently,
Ci processing is reduced, full-length Ci (Ci155) accumulates and the
transcription of Hh target genes is activated. Inhibitory proteins are
shown in pink; activating proteins in green; black boxes represent
direct molecular interactions already demonstrated (present work and
[6,7]); grey boxes represent putative molecular interactions.
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Hh signalling pathway and the fact that the domains
mediating the molecular interactions described here have
also been conserved throughout evolution, it is highly
probable that comparable molecular interactions also exist
in vertebrates.
Materials and methods
Two-hybrid assays
The yeast strain EGY48 containing the lacZ reporter plasmid pSH18-
34, was co-transformed with a pEG202 derivative containing the LexA
fusions, and a pJG4-5 derivative containing the B42 fusions [9]. Rab3
and GGTIIβ are two human proteins known to interact. In
pYeF2–Su(fu), the complete Su(fu) coding sequence was placed
under the control of a GAL10–CYC1 hybrid promoter. The β-galactosi-
dase filter assay was performed on filters after growth on SCgal-UHW
plates. The LEU2 assay was done by testing the growth of yeast cells
on SCgal-UHWL.
GST fusion protein binding assays
The complete Su(fu) coding sequence was fused to the carboxyl termi-
nus of GST. Purification of GST fusion proteins was performed as in
[14]. In vitro translated proteins ([35S]methionine-labelled Fu, Ci and
77K) were obtained by means of the TNT Reticulocyte Lysate System
of Promega. We always used the same amounts of GST and GST-
fusion proteins. The interaction and washing buffers contained 100 mM
and 200 mM KCl, respectively. 
Immunoprecipitations
The immunoprecipitations were performed with a rabbit antiserum
directed against Su(fu) (our unpublished results). Equivalent amounts
of embryonic extracts were used after quantification with Bio-Rad
Protein Assay and checked by western analysis. Immunoprecipitation
conditions were as in [15] with 125 mM NaCl and 0.1% IGEPAL CA-
630. We subjected the immunoprecipitates to western analysis, using
the Ci monoclonal antibody mAb 2A1. 
Supplementary material
A table documenting levels of β-galactosidase activity, and details of
the plasmids, strains and methods are published with this paper on the
internet. 
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Materials and methods
Yeast strain, media and procedures
The Saccharomyces cerevisiae strain EGY48 (MATα, his3, trp1, ura3-
52, leu2:pLEU2-LexAop6) was provided by R. Brent [S1]. Yeast cultures
were grown in Synthetic Complete (SC) medium with either 2% glucose
in SCglu or 2% galactose plus 1% raffinose in SCgal, complemented
with all appropriate amino acids and bases minus those required for
plasmid selection (for example, SC-HLUW lacks histidine, leucine, uracil
and tryptophan). Yeast cells were transformed according to the lithium
acetate procedure as in [S2] with minor modifications. Escherichia coli
DH5α cells were transformed by the rubidium chloride procedure [S3].
Plasmids
The two-hybrid expression vectors were derived from pEG202 and
pJG4-5. pSH18-34 is a multicopy plasmid that carries the lacZ reporter
[S4]. Su(fu) and Ci were expressed as full-length proteins fused at their
amino termini to the carboxyl terminus of LexA (pEGSu(fu)) or B42
(pJGCi), respectively. In pEGSu(fu), the complete coding sequence of
Su(fu) was inserted into the EcoRI site of pEG202. In pJGCi, we
inserted the entire coding sequence of Ci into the EcoRI site of pJG4-
5, with three extra amino acids (GIR, single-letter amino-acid code) at
the junction between B42 and Ci. pEGCi-∆346 contained a partially
unspliced Ci cDNA which resulted in the expression of the first 346
amino acids followed by three extra residues (GNC). The regulatory
domain of Fu (Fu-reg: amino acids 306–805) was cloned in-frame in
pJG4-5 at the EcoRI site. Deletions of the regulatory domain of Fu
were as follows: pJGFu-reg-∆1 encodes amino acids 306–581 of Fu;
pJGFu-reg-∆2 amino acids 582–805; pJGFu-reg-∆3 amino acids
437–581; pJGFu-reg-∆4: amino acids 306–436. All Fu constructs
contain two extra glycines at the junction with B42. We checked all in-
frame junctions using Sequenase version 2.0 (USB). Rab3 (a
monomeric GTP-binding protein) and GGTIIβ (the β-subunit of geranyl-
geranyl transferase) are two human proteins known to interact with
each other [S5].
pYeFSu(fu) was derived from pYeF2 [S6], leading to a transcriptional
fusion between a GAL10–CYC1 hybrid promotor and the complete
Su(fu) coding sequence. GST–Su(fu) is a translational fusion between
the glutathione-S-transferase domain (GST) and the entire Su(fu)
protein expressed from a pGEX-3X vector. Ten extra amino acids
(IPAMEAEPMA) were added at the GST–Su(fu) junction. 
Two-hybrid assays
Transformants were selected on SCglu-UHW. Single colonies were
resuspended in 10 µl water. For the β-galactosidase filter assays, 1/3
of the suspension was put on Whatman 40 filters placed on SCgal-
UHW plates. After overnight incubation at 30°C, the filters were frozen
in liquid nitrogen for 20 sec, placed on Whatman 3MM filters soaked
with 0.4 mg/ml X-gal in Z buffer and incubated at 30°C. The reaction
was stopped by transferring the filters to 1 M Na2CO3. For the LEU2
activity assay, 3 µl of the same yeast cell suspension diluted 10-fold
were deposited onto SCgal-UHWL. Growth was observed after 24,
36, and 48 h incubation at 30°C.
The β-galactosidase activity (in arbitrary units) was quantified following
the procedure described in [S7]. It was calculated as OD420/(t × OD600);
t being the time of reaction (in min). 
GST fusion protein binding assays
Purification of GST fusion proteins was performed as in [S8]. We
obtained in vitro translated proteins ([35S]methionine-labelled Fu, Ci
and 77K) using the TNT reticulocyte lysate system of Promega accord-
ing to the manufacturer’s instructions. [35S]methionine-labelled pro-
teins (10 µl) previously incubated with free beads were mixed with a
comparable amount of GST–Su(fu) or GST bound to beads previously
incubated with 1% BSA (w/v) in interaction buffer A. After 1 h at 4°C,
the beads were washed three times with 1 ml washing buffer (buffer A
containing 200 mM KCl). The fractions were analysed on a 8%
SDS–polyacrylamide gel. The human polyadenylation protein 77K was
used as a control [S9].
Immunoprecipitations
Antiserum directed against Su(fu) was raised in a rabbit against the
bacterially expressed GST–Su(fu) and purified by affinity against a
MalE–Su(fu) column. Purified antibodies were linked to protein
A–sepharose beads (Pierce Immuno Pure IgG Orientation Kit;
6.25 mg anti-Su(fu) antibodies linked to 2 ml activated protein
A–sepharose beads).
Immunoprecipitations were performed as in [S10] with minor modifica-
tions. The embryonic extracts (250 embryos in 100 µl lysis buffer (K+
HEPES 50 mM, NaCl 25 mM, EGTA 1 mM, NaF 100 mM,
Na3VO4 1mM, PMSF 2 mM, leupeptin 10 µg/ml)) were precleared with
protein A–sepharose. Precleared samples were incubated with 30µl
anti-Su(fu) antibodies linked to protein A–sepharose for 2 h at 4°C and
washed with lysis buffer. The amount of protein in the extracts was quan-
tified with the Bio-Rad protein assay and checked by western analysis.
For immunoblot analysis, we subjected samples (1/50 of supernatant;
all of the immunoprecipitates) to electrophoresis on 8% SDS–polyacry-
lamide gels and then transferred them to nitrocellulose membrane,
using a semidry blotting apparatus. Membranes were blocked in blotto
(5% nonfat dry milk in TBS, 0.1% Tween 20) for 90 min and incubated
with the anti-Ci monoclonal antibody mAb 2A1 mixed in TBS, 0.1%
Tween 20 and 5% BSA overnight at 4°C. Membranes were then incu-
bated with a sheep secondary antibody conjugated to peroxidase and
Supplementary material
Table S1
b-galactosidase activity.
Hybrid proteins LexA–Rab3 LexA–Su(fu)
B42–GGTΙΙβ n.d. 5.7 ± 4.1
B42–Ci 25 ± 2.1 1000 ± 78
B42–Fu-reg 6.8 ± 3.0 800 ± 200
β-galactosidase activity was induced by Su(fu)–Ci and Su(fu)–Fu-reg
interactions. See also legend to Figure 1. 
β-galactosidase activity (arbitrary units) = OD420/(t × OD600) where t is
the time of reaction (in min) at 30°C. Values correspond to the mean of
two assays with independent transformants. n.d., not done.
developed by enhanced chemiluminescence (Amersham ECL kit). The
co-immunoprecipitations were reproduced three independent times.
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